Cheryl A Passanisi, NP

Offices

1 location · Stanford Health Care · 3,152 clinicians in this group

Looking this up.

Hospitals listed: Stanford Health Care. That is not proof they admit you there this week.

Plan participation

Not verified

We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Cheryl A Passanisi’s office at (650) 723-4000 to ask if they take your plan before you enroll.

Hospitals they work in

1 hospital

These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.

Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend it
Overall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024

See every measure and the patient survey for Stanford Health Care

Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Sort by

Every scored measure at Stanford Health Care

Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths	5.31 (4.24 to 6.37) · 8,661 cases	Worse	Jul 2022 – Jun 2024
Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits	14.1 (12.7 to 15.7) · 2,191 cases	Worse	Jan 2024 – Dec 2024
Postoperative respiratory failure rateComplications and deaths	4.08 (1.95 to 6.21) · 5,296 cases	Better	Jul 2022 – Jun 2024
Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections	0.317	Better	Oct 2024 – Sep 2025
Clostridium Difficile (C.Diff)Infections	0.446	Better	Oct 2024 – Sep 2025
SSI - Colon SurgeryInfections	0.241	Better	Oct 2024 – Sep 2025
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits	0.7 (0.6 to 0.9) · 3,348 cases	Better	Jan 2024 – Dec 2024
Abdominopelvic accidental puncture or laceration rateComplications and deaths	1.06 (0.45 to 1.67) · 5,374 cases	No different	Jul 2022 – Jun 2024
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths	0.86 (0.72 to 1)	No different	Jul 2022 – Jun 2024
Death rate among surgical inpatients with serious treatable complicationsComplications and deaths	166.09 (137.88 to 194.3) · 470 cases	No different	Jul 2022 – Jun 2024
Death rate for CABG surgery patientsComplications and deaths	1.1 · 192 cases	None	Jul 2022 – Jun 2025
Death rate for COPD patientsComplications and deaths	6.4 · 146 cases	None	Jul 2022 – Jun 2025
Death rate for heart attack patientsComplications and deaths	9.7 · 253 cases	None	Jul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths	6.3 · 880 cases	None	Jul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths	10.3 · 935 cases	None	Jul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths	8.7 · 501 cases	None	Jul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths	2.1 · 7,730 cases	None	Jul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths	0.13 (0 to 0.27) · 20,799 cases	No different	Jul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths	0.28 (0.14 to 0.43) · 23,182 cases	No different	Jul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths	0.94 (0.2 to 1.68) · 5,694 cases	No different	Jul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths	2.36 (1.54 to 3.19) · 7,846 cases	No different	Jul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths	5.2 (3.76 to 6.64) · 5,603 cases	No different	Jul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths	1.38 (0.23 to 2.53) · 2,211 cases	No different	Jul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths	0.52 (0.21 to 0.83) · 19,915 cases	No different	Jul 2022 – Jun 2024
Rate of complications for hip/knee replacement patientsComplications and deaths	3.6 · 416 cases	None	Apr 2023 – Mar 2025
Central Line Associated Bloodstream Infection (ICU + select Wards)Infections	0.869	No different	Oct 2024 – Sep 2025
MRSA BacteremiaInfections	0.857	No different	Oct 2024 – Sep 2025
SSI - Abdominal HysterectomyInfections	0.368	No different	Oct 2024 – Sep 2025
Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits	16.2 · 247 cases	None	Jul 2023 – Jun 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits	20.5 · 1,021 cases	None	Jul 2023 – Jun 2025
Hospital return days for heart attack patientsUnplanned return visits	47.8 · 258 cases	None	Jul 2022 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits	-1.6 · 990 cases	None	Jul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits	20.8 · 976 cases	None	Jul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits	16.5 · 959 cases	None	Jul 2023 – Jun 2025
Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits	5.2 (4.4 to 6.2) · 2,191 cases	No different	Jan 2024 – Dec 2024
Rate of readmission after hip/knee replacementUnplanned return visits	5.1 · 425 cases	None	Jul 2023 – Jun 2025
Rate of readmission for CABGUnplanned return visits	9.6 · 158 cases	None	Jul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits	19.6 · 183 cases	None	Jul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits	12.7 (10.4 to 15.4) · 4,578 cases	No different	Jan 2022 – Dec 2024

What patients said (6,810 patients answered, 25% of those asked)

Sort by

Patient survey stars by topic at Stanford Health Care

Cleanliness	4
Nurse communication	4
Doctor communication	4
Communication about medicines	3
Discharge information	4
Overall hospital rating	4
Quietness	2
Recommend hospital	5

Sort by

Share of patients giving the best answer at Stanford Health Care

Room was "always" clean	75%
Nurses "always" communicated well	82%
Doctors "always" communicated well	81%
Staff "always" explained	63%
Yes, staff "did" give patients this information	89%
Yes, staff "did" give patients information about help after discharge	89%
Doctors "always" explained things so they could understand	76%
Doctors "always" listened carefully	80%
Doctors "always" treated them with courtesy and respect	87%
Patients who gave a rating of "9" or "10" (high)	79%
Staff "always" explained new medications	76%
Nurses "always" explained things so they could understand	77%
Nurses "always" listened carefully	79%
Nurses "always" treated them with courtesy and respect	88%
"Always" quiet at night	53%
"YES", patients would definitely recommend the hospital	83%
Staff "always" explained possible side effects	50%
Yes, staff "did" give patients information about possible symptoms	90%

Original Medicare doctor bills

$16,029

Medicare paid this office $16,029 for 149 people. Most of that is long return visits and Botox.

This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.

Sort by

Largest Original Medicare bills

Long return visit (40+ min)	49	$7,432	$111
Biopsy and aspiration of bone marrow sample for diagnosis	79	$4,765	$57
Return visit (30+ min)	15	$2,006	$74

Who their Medicare patients are

149 Original Medicare patients in 2024. Average age 75 · Women 48% · Also on Medicaid 22% · Health risk score 2.71. Above the middle of the specialty; the typical nurse practitioner clinician is at 1.42.

Conditions among them: High blood pressure 73% · Chronic kidney disease 34% · Diabetes 30% · Heart failure 29% · Coronary heart disease 28% · Atrial fibrillation 24% · Cancer 22% · Depression 17% · COPD 13% · Dementia 13% · Stroke 9%.

The office billed $112,548, Medicare allowed $20,166 and paid $16,029; for 222 services of 16 kinds.

Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.

Year by year

Sort by

Original Medicare by year

2024	149	222	75	2.71	$112,548	$16,029
2023	143	205	74	2.49	$94,335	$13,874
2022	140	194	73	2.58	$70,041	$11,955
2021	125	157	74	2.74	$43,687	$10,584
2020	92	116	74	2.63	$63,861	$6,955
2019	57	67	73	2.91	$48,813	$3,469
2018	70	76	73	3.03	$57,238	$4,178
2017	102	186	72	2.17	$251,500	$7,126
2016	43	89	70	2.67	$141,517	$3,091

Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.

See the services billed each year

2023: 6 services

Sort by

Original Medicare services billed in 2023

Long return visit (40+ min)	29	$4,806	$109
Biopsy and aspiration of bone marrow sample for diagnosis	63	$3,809	$58
Return visit (30+ min)	26	$2,994	$77
Administration of chemotherapy into fluid-filled space between the tissue that cover the brain and spinal cord	12	$1,015	$60
Short return visit (20+ min)	15	$830	$52
Office for the evaluation and management of established patient that may not require presence of healthcare professional	11	$76	$7

2022: 4 services

Sort by

Original Medicare services billed in 2022

Biopsy and aspiration of bone marrow sample for diagnosis	78	$4,362	$56
Return visit (30+ min)	24	$3,233	$77
Long return visit (40+ min)	19	$2,725	$118
Office for the evaluation and management of established patient that may not require presence of healthcare professional	18	$126	$7

2021: 5 services

Sort by

Original Medicare services billed in 2021

Biopsy and aspiration of bone marrow sample for diagnosis	64	$3,887	$60
Long return visit (40+ min)	20	$3,536	$122
Return visit (30+ min)	21	$1,904	$76
Short return visit (20+ min)	11	$587	$53
Office for the evaluation and management of established patient that may not require presence of healthcare professional	14	$93	$6

2020: 3 services

Sort by

Original Medicare services billed in 2020

Biopsy and aspiration of bone marrow sample for diagnosis	47	$2,990	$60
Long return visit (40+ min)	13	$1,399	$93
Return visit (30+ min)	17	$1,125	$59

2019: 1 service

Sort by

Original Medicare services billed in 2019

Biopsy and aspiration of bone marrow sample for diagnosis	32	$1,851	$54

2018: 1 service

Sort by

Original Medicare services billed in 2018

Biopsy and aspiration of bone marrow sample for diagnosis	57	$3,340	$57

2017: 2 services

Sort by

Original Medicare services billed in 2017

Biopsy of bone marrow	87	$5,319	$58
Bone marrow aspiration performed with bone marrow biopsy through the same incision on the same date of service	65	$465	$7

2016: 2 services

Sort by

Original Medicare services billed in 2016

Biopsy of bone marrow	37	$2,140	$55
Bone marrow aspiration performed with bone marrow biopsy through the same incision on the same date of service	35	$241	$7

Drugs they prescribed that Part D paid

$4,736,983

Pharmacies billed $4,736,983 in 2024.

This is pharmacy cost, not the office bill, and not what patients paid.

0 generic and 323 brand-name prescriptions · $4,736,983 in drug cost · 35 antibiotic prescriptions to 21 people.

Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.

Sort by

Largest Part D drug costs

Calquence	52	$771,338	$14,833
Imbruvica	36	$607,564	$16,877
Revlimid	30	$565,909	$18,864
Brukinsa	43	$524,838	$12,206
Pomalyst	23	$472,815	$20,557

See all 17 drugs

Sort by

Every Part D drug this clinician prescribed

Calquence	52	$771,338	$14,833
Imbruvica	36	$607,564	$16,877
Revlimid	30	$565,909	$18,864
Brukinsa	43	$524,838	$12,206
Pomalyst	23	$472,815	$20,557
Jakafi	18	$308,186	$17,121
Lenalidomide	18	$257,785	$14,321
Venclexta	18	$227,319	$12,629
Sprycel	15	$136,307	$9,087
Deferasirox	12	$63,111	$5,259
Imatinib Mesylate	13	$19,263	$1,482
Eliquis	16	$9,253	$578
Hydroxyurea	38	$1,394	$37
Acyclovir	38	$677	$18
Levofloxacin	22	$510	$23
Methotrexate	14	$278	$20
Dexamethasone	17	$214	$13

Year by year

Sort by

Part D prescribing by year

2024	622	220	None	52%	$4,736,983
2023	429	161	4% (19)	None	$1,951,728
2022	398	137	6% (22)	None	$1,620,927
2021	441	137	3% (13)	None	$1,668,251
2020	503	151	5% (26)	None	$2,094,445
2019	247	93	8% (20)	47%	$742,413
2018	200	64	9% (18)	40%	$447,146
2017	162	61	17% (27)	23%	$159,368
2016	108	45	13% (14)	33%	$334,265

Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.

See the drugs prescribed each year

2023: 11 drugs

Sort by

Part D drugs prescribed in 2023

Jakafi	19	$349,475	$18,393
Venclexta	35	$344,327	$9,838
Pomalyst	14	$275,938	$19,710
Revlimid	14	$254,835	$18,203
Brukinsa	12	$170,835	$14,236
Eliquis	20	$12,647	$632
Acyclovir	44	$1,335	$30
Hydroxyurea	21	$985	$47
Valacyclovir	11	$650	$59
Dexamethasone	23	$208	$9
Methotrexate	14	$176	$13

2022: 9 drugs

Sort by

Part D drugs prescribed in 2022

Jakafi	25	$446,038	$17,842
Imbruvica	21	$330,802	$15,752
Venclexta	28	$279,064	$9,967
Xarelto	19	$12,760	$672
Hydroxyurea	18	$1,284	$71
Acyclovir	55	$1,191	$22
Dexamethasone	20	$259	$13
Allopurinol	14	$151	$11
Prednisone	14	$36	$3

2021: 14 drugs

Sort by

Part D drugs prescribed in 2021

Imbruvica	35	$514,827	$14,709
Venclexta	27	$285,286	$10,566
Jakafi	14	$175,646	$12,546
Calquence	12	$157,897	$13,158
Pegasys	13	$50,917	$3,917
Deferasirox	11	$35,418	$3,220
Xarelto	41	$28,131	$686
Imatinib Mesylate	20	$21,099	$1,055
Eliquis	16	$8,120	$508
Vagifem	13	$2,341	$180
Hydroxyurea	38	$1,053	$28
Acyclovir	30	$676	$23
Ondansetron Odt	15	$442	$29
Allopurinol	28	$278	$10

2020: 11 drugs

Sort by

Part D drugs prescribed in 2020

Imbruvica	58	$618,564	$10,665
Jakafi	20	$316,417	$15,821
Venclexta	30	$257,612	$8,587
Sprycel	15	$224,966	$14,998
Imatinib Mesylate	22	$71,679	$3,258
Eliquis	36	$20,526	$570
Xarelto	30	$18,265	$609
Hydroxyurea	28	$993	$35
Acyclovir	41	$874	$21
Pantoprazole	13	$323	$25
Allopurinol	16	$79	$5

2019: 7 drugs

Sort by

Part D drugs prescribed in 2019

Imbruvica	31	$293,273	$9,460
Sprycel	12	$159,315	$13,276
Venclexta	15	$115,614	$7,708
Xarelto	20	$11,863	$593
Eliquis	19	$9,397	$495
Acyclovir	24	$471	$20
Dexamethasone	11	$143	$13

2018: 6 drugs

Sort by

Part D drugs prescribed in 2018

Jakafi	16	$176,775	$11,048
Imbruvica	11	$125,200	$11,382
Xarelto	21	$8,843	$421
Acyclovir	23	$261	$11
Prednisone	14	$110	$8
Amlodipine Besylate	11	$23	$2

2017: 2 drugs

Sort by

Part D drugs prescribed in 2017

Acyclovir	20	$264	$13
Prednisone	12	$44	$4

2016: 1 drug

Sort by

Part D drugs prescribed in 2016

Jakafi	12	$128,798	$10,733

Money from drug and device companies

$1,804 in 2025

Sort by

Industry payments by year

2025	17	53	None	$1,804
2024	13	33	None	$1,055
2023	12	20	None	$665
2022	6	13	None	$352
2021	3	4	None	$158

Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.

A payment is not proof that care is biased.

Sort by

Payments by company

Rigel Pharmaceuticals	Tavalisse	$256	6 payments Meals for Rezlidhia · 2025-11-17 · $121 Meals for Tavalisse · 2025-09-22 · $30 Meals for Tavalisse · 2025-09-22 · $19 Meals for Tavalisse · 2025-04-02 · $32 Meals for Tavalisse · 2025-02-25 · $28 Meals for Tavalisse · 2025-01-22 · $25
E.R. Squibb & Sons L.L.C.	Opdivo	$249	2 payments Meals for Opdivo · 2025-09-09 · $122 Meals for Opdivo · 2025-02-11 · $128
Daiichi Sankyo	Vanflyta	$244	12 payments Meals for Vanflyta · 2025-11-12 · $29 Meals for Vanflyta · 2025-09-29 · $30 Meals for Vanflyta · 2025-07-31 · $29 Meals for Enhertu · 2025-07-29 · $13 Meals for Injectafer · 2025-06-10 · $28 Meals for Datroway · 2025-06-10 · $12 Meals for Injectafer · 2025-05-20 · $25 Meals for Injectafer · 2025-04-29 · $2 Meals for Injectafer · 2025-04-29 · $12 Meals for Vanflyta · 2025-04-17 · $26 Meals for Enhertu · 2025-03-31 · $9 Meals for Vanflyta · 2025-02-28 · $29
Syndax Pharmaceuticals	Revuforj	$195	3 payments Meals · 2025-10-23 · $24 Meals for Revuforj · 2025-05-13 · $147 Meals · 2025-03-05 · $24
Janssen Biotech	Talvey	$185	5 payments Meals for Talvey · 2025-11-10 · $39 Meals for Talvey · 2025-10-06 · $26 Meals for Talvey · 2025-08-18 · $34 Meals for Darzalex · 2025-06-24 · $70 Meals for Darzalex · 2025-05-29 · $16
PharmaEssentia USA	Besremi	$165	5 payments Meals for Besremi · 2025-10-27 · $19 Meals for Besremi · 2025-10-27 · $3 Meals for Besremi · 2025-06-24 · $19 Meals for Besremi · 2025-06-23 · $3 Meals for Besremi · 2025-01-27 · $122

See all 53 published payments

Sort by

Every published payment

GlaxoSmithKline	Meals · 2025-12-02	Blenrep	$17
Stemline Therapeutics	Meals · 2025-11-29	Elzonris	$29
Takeda Pharmaceuticals U.S.A.	Meals · 2025-11-18	Vonvendi	$30
Rigel Pharmaceuticals	Meals · 2025-11-17	Rezlidhia	$121
Daiichi Sankyo	Meals · 2025-11-12	Vanflyta	$29
Kite Pharma	Meals · 2025-11-11	Yescarta	$31
Janssen Biotech	Meals · 2025-11-10	Talvey	$39
BeOne Medicines USA	Meals · 2025-11-04	Brukinsa	$29
Merck Sharp & Dohme	Meals · 2025-10-28	Keytruda	$28
PharmaEssentia USA	Meals · 2025-10-27	Besremi	$19
PharmaEssentia USA	Meals · 2025-10-27	Besremi	$3
Syndax Pharmaceuticals	Meals · 2025-10-23	None	$24
Merck Sharp & Dohme	Meals · 2025-10-14	Keytruda	$27
Celgene	Meals · 2025-10-07	Reblozyl	$18
AstraZeneca Pharmaceuticals LP	Meals · 2025-10-07	Calquence	$25
Janssen Biotech	Meals · 2025-10-06	Talvey	$26
Daiichi Sankyo	Meals · 2025-09-29	Vanflyta	$30
BeOne Medicines USA	Meals · 2025-09-29	Brukinsa	$29
Rigel Pharmaceuticals	Meals · 2025-09-22	Tavalisse	$30
Rigel Pharmaceuticals	Meals · 2025-09-22	Tavalisse	$19
E.R. Squibb & Sons L.L.C.	Meals · 2025-09-09	Opdivo	$122
BeOne Medicines USA	Meals · 2025-09-08	Brukinsa	$33
Janssen Biotech	Meals · 2025-08-18	Talvey	$34
AstraZeneca Pharmaceuticals LP	Meals · 2025-08-13	Calquence	$23
Daiichi Sankyo	Meals · 2025-07-31	Vanflyta	$29
Daiichi Sankyo	Meals · 2025-07-29	Enhertu	$13
Takeda Pharmaceuticals U.S.A.	Meals · 2025-07-29	Vonvendi	$23
Regeneron Healthcare Solutions	Meals · 2025-07-28	Lynozyfic	$24
Abbvie	Meals · 2025-07-15	Imbruvica	$24
Janssen Biotech	Meals · 2025-06-24	Darzalex	$70
PharmaEssentia USA	Meals · 2025-06-24	Besremi	$19
PharmaEssentia USA	Meals · 2025-06-23	Besremi	$3
BeOne Medicines USA	Meals · 2025-06-16	Brukinsa	$31
Daiichi Sankyo	Meals · 2025-06-10	Injectafer	$28
Daiichi Sankyo	Meals · 2025-06-10	Datroway	$12
Janssen Biotech	Meals · 2025-05-29	Darzalex	$16
Daiichi Sankyo	Meals · 2025-05-20	Injectafer	$25
Syndax Pharmaceuticals	Meals · 2025-05-13	Revuforj	$147
Daiichi Sankyo	Meals · 2025-04-29	Injectafer	$2
Daiichi Sankyo	Meals · 2025-04-29	Injectafer	$12
Celgene	Meals · 2025-04-22	Opdivo	$16
Daiichi Sankyo	Meals · 2025-04-17	Vanflyta	$26
AstraZeneca Pharmaceuticals LP	Meals · 2025-04-15	Calquence	$22
Rigel Pharmaceuticals	Meals · 2025-04-02	Tavalisse	$32
Daiichi Sankyo	Meals · 2025-03-31	Enhertu	$9
Syndax Pharmaceuticals	Meals · 2025-03-05	None	$24
Daiichi Sankyo	Meals · 2025-02-28	Vanflyta	$29
Rigel Pharmaceuticals	Meals · 2025-02-25	Tavalisse	$28
E.R. Squibb & Sons L.L.C.	Meals · 2025-02-11	Opdivo	$128
Incyte	Meals · 2025-01-28	Jakafi	$27
PharmaEssentia USA	Meals · 2025-01-27	Besremi	$122
Rigel Pharmaceuticals	Meals · 2025-01-22	Tavalisse	$25
Kite Pharma	Meals · 2025-01-21	Yescarta	$24

See earlier years (2024, 2023, 2022, 2021)

2024: $1,055

Sort by

Payments by company in 2024

Abbvie	Venclexta	$428	8 payments Meals for Venclexta · 2024-11-19 · $125 Meals for Venclexta · 2024-05-15 · $23 Meals for Imbruvica · 2024-05-09 · $29 Meals for Imbruvica · 2024-05-09 · $6 Meals for Imbruvica · 2024-05-09 · $2 Meals for Venclexta · 2024-04-09 · $125 Meals for Venclexta · 2024-03-26 · $88 Meals for Epkinly · 2024-03-19 · $31
AstraZeneca Pharmaceuticals LP	Calquence	$226	8 payments Meals for Calquence · 2024-11-25 · $28 Meals for Calquence · 2024-11-05 · $28 Meals for Calquence · 2024-09-24 · $31 Meals for Enhertu · 2024-07-11 · $20 Meals for Enhertu · 2024-07-10 · $4 Meals for Calquence · 2024-06-11 · $64 Meals for Calquence · 2024-04-16 · $22 Meals for Calquence · 2024-01-30 · $29
Rigel Pharmaceuticals	Rezlidhia	$78	4 payments Meals for Rezlidhia · 2024-06-26 · $21 Meals for Rezlidhia · 2024-03-05 · $29 Meals for Rezlidhia · 2024-01-23 · $26 Meals for Rezlidhia · 2024-01-23 · $2
Janssen Biotech	Darzalex	$60	2 payments Meals for Darzalex · 2024-12-16 · $23 Meals for Darzalex · 2024-08-27 · $36
Ipsen Biopharmaceuticals	Onivyde	$55	2 payments Meals for Onivyde · 2024-11-21 · $32 Meals for Onivyde · 2024-08-29 · $23
Daiichi Sankyo	Vanflyta	$38	2 payments Meals for Vanflyta · 2024-12-11 · $21 Meals for Vanflyta · 2024-10-01 · $17
Celgene	Pomalyst	$29	1 payment Meals for Pomalyst · 2024-04-17 · $29
Merck Sharp & Dohme	Keytruda	$29	1 payment Meals for Keytruda · 2024-09-10 · $29
Servier Pharmaceuticals	Oncaspar	$24	1 payment Meals for Oncaspar · 2024-05-28 · $24
Adaptive Biotechnologies	Clonoseq	$23	1 payment Meals for Clonoseq · 2024-12-03 · $23
Pfizer	Bosulif	$23	1 payment Meals for Bosulif · 2024-08-29 · $23
PharmaEssentia USA	Besremi	$21	1 payment Meals for Besremi · 2024-12-17 · $21
Lilly USA	Verzenio	$20	1 payment Meals for Verzenio · 2024-11-12 · $20

2023: $665

Sort by

Payments by company in 2023

Incyte	Jakafi	$237	3 payments Education · 2023-10-23 · $91 Meals for Jakafi · 2023-06-06 · $125 Meals for Jakafi · 2023-05-10 · $21
AstraZeneca Pharmaceuticals LP	Calquence	$86	2 payments Meals for Calquence · 2023-08-30 · $31 Meals for Calquence · 2023-05-23 · $55
Pharmacyclics LLC An AbbVie	Imbruvica	$71	2 payments Meals for Imbruvica · 2023-03-08 · $41 Meals for Imbruvica · 2023-01-07 · $30
Rigel Pharmaceuticals	Rezlidhia	$62	4 payments Meals for Rezlidhia · 2023-11-07 · $25 Meals for Rezlidhia · 2023-10-31 · $3 Meals for Rezlidhia · 2023-09-05 · $30 Meals for Rezlidhia · 2023-09-05 · $5
Merck Sharp & Dohme	Keytruda	$33	1 payment Meals for Keytruda · 2023-10-04 · $33
Amgen	Nplate	$28	1 payment Meals for Nplate · 2023-06-20 · $28
CTI BioPharma	Vonjo	$28	1 payment Meals for Vonjo · 2023-04-25 · $28
Janssen Biotech	Darzalex	$27	2 payments Meals for Darzalex · 2023-12-04 · $14 Meals for Rybrevant · 2023-06-28 · $13
Servier Pharmaceuticals	Oncaspar	$25	1 payment Meals for Oncaspar · 2023-01-24 · $25
BeiGene USA	Brukinsa	$24	1 payment Meals for Brukinsa · 2023-02-14 · $24
Kite Pharma	Yescarta	$23	1 payment Meals for Yescarta · 2023-11-28 · $23
GlaxoSmithKline	Ojjaara	$20	1 payment Meals for Ojjaara · 2023-11-13 · $20

2022: $352

Sort by

Payments by company in 2022

Amgen	Kyprolis	$131	2 payments Meals for Kyprolis · 2022-10-18 · $105 Meals for Kyprolis · 2022-09-12 · $27
Janssen Biotech	Imbruvica	$117	6 payments Meals for Imbruvica · 2022-12-19 · $24 Meals for Carvykti · 2022-10-26 · $24 Meals for Imbruvica · 2022-10-18 · $19 Meals for Darzalex · 2022-07-27 · $21 Meals for Imbruvica · 2022-07-25 · $9 Meals for Carvykti · 2022-07-19 · $20
Pharmacyclics LLC an AbbVie	Imbruvica	$44	2 payments Meals for Imbruvica · 2022-09-27 · $20 Meals for Imbruvica · 2022-07-25 · $24
AstraZeneca Pharmaceuticals LP	Calquence	$29	1 payment Meals for Calquence · 2022-01-20 · $29
Servier Pharmaceuticals	Oncaspar	$17	1 payment Meals for Oncaspar · 2022-02-15 · $17
Novartis Pharmaceuticals	Scemblix	$13	1 payment Meals for Scemblix · 2022-01-25 · $13

2021: $158

Sort by

Payments by company in 2021

Amgen	Blincyto	$117	2 payments Meals for Blincyto · 2021-07-26 · $17 Education · 2021-03-16 · $100
AbbVie	Venclexta	$25	1 payment Meals for Venclexta · 2021-11-08 · $25
Janssen Biotech	Darzalex	$16	1 payment Meals for Darzalex · 2021-12-20 · $16

Checkups this office reported

Medicare did not publish checkup rates for this clinician.

Medicare’s overall office score: 76.5 / 100; Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.

Professional record

NPI: 1497122360
Licence: CA 326872, CA 95001605
Group: Stanford Health Care
Video visits: Lists video visits
Gender: Female

More record details

Sole proprietor: No
Taxonomy: Federal specialty code 363LA2200X (363LA2200X); Nurse practitioner (363L00000X); Federal specialty code 363LA2100X (363LA2100X); Federal specialty code 363LG0600X (363LG0600X)
Mailing address: 300 Pasteur Dr, Stanford, CA, 94305
NPI first listed: 2015-08-27
NPI last updated: 2025-12-30
NPI record certified: 2025-12-30

This is when the NPI record was last certified, not a medical board exam.